CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam  ¹     Ellen J. Scherl  ²     David Rowbotham  ³     Silvio Danese  ⁴     William Sandborn  ⁵     Ye Miao  ⁶     Hongyan Zhang  ⁶     Remo Panaccione  ⁷     Waqqas Afif  ⁸     Tadakazu Hisamatsu  ⁹     Rupert W Leong  ¹⁰     Bruce E. Sands  ¹¹     Maria T. Abreu  ¹²     Colleen W. Marano  ^12    
1 Warwick Medical School, University of Warwick & University Hospital Coventry, Coventry Warwickshire
² Weill Cornell Medicine, New York Presbyterian Hospital, New York, United States
³ Auckland City Hospital, Auckland, New Zealand
⁴ Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
⁵ University of California San Diego, San Diego, United States
⁶ Janssen Research & Development, LLC, Spring House
⁷ University of Calgary, Calgary, Canada
⁸ McGill University Health Center, Montreal, Canada
⁹ Kyorin University, Tokyo, Japan
¹⁰ Concord Hospital Dept. of Gastroenterology, Sydney, Australia
¹¹ Icahn School of Medicine at Mount Sinai, New York, United States
¹² University of Miami, Miller School of Medicine, Miami, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)